Red Door Communications has bolstered its senior account handling team by re-hiring Sarah Aldridge as account director. Aldridge (pictured) has …
The risk to the global pharmaceutical supply chain from counterfeit drugs grows ever year, and costs companies billions in lost …
Boehringer Ingelheim’s once-daily bronchodilator olodaterol has improved lung function versus placebo in a Phase II trial. The manufacturer wants the …

There are at least two perspectives of what ‘Medical Education’ means, and certainly many definitions.For doctors and other healthcare professionals, …
Contract research and manufacturing organisation AMRI has announced the appointment of Ian Shott as president of AMRI Europe. In this …

NICE is recommending Bayer’s anticoagulant pill Xarelto to help reduce the risk of stroke in certain patients. The watchdog’s final …

The NHS will host its first ‘hack day’ event this weekend in London, with the aim of sharing software that …

The Department of Health has outlined its plan for greater use of information technology in the NHS in a bid …
Excipients trade body IPEC will set up a branch in India next month, plus updates for Codexis, SGS International, Vetter …

Strategic marketing firm The MSI Consultancy has appointed Oliver Leatham as market access consultant. Oliver has a wide experience as …

Avalanche Biotechnologies, a US company developing gene therapies for ocular diseases, has signed a manufacturing collaboration with Lonza of Switzerland. …
Médecins Sans Frontières is urging health ministers around the world to create an ‘R&D Convention’ to ensure that pharma helps …

Pfizer has said it plans to cut 40% of jobs at a manufacturing facility in Manitoba, Canada, that supplies the …
Events 4 Healthcare is delighted that Sir Gordon Duff will be chairing this year’s Clinical Discovery Annual Conference on 16 …
Mitsubishi Tanabe Pharma has said it will withdraw from the fine chemical business, including active pharmaceutical ingredient (API) supply, and …
Bridgend, Wales: Biotec Services International has announced the appointment of two senior industry professionals as the company embarks on an …

UCB has signed a two-year research deal with Imperial College London to find disease-modifying targets in epilepsy. The firm has …
ICON has appointed Dr Susan Anton as director of epidemiology and risk management practice, and late phase and outcomes research. …
A charity which aims to increase the chances of survival for patients with a poorly-treated form of cancer is to …

Canada has approved the world’s first stem cell drug, marking an historic day for the burgeoning therapy. Osiris’ Prochymal is …